Literature DB >> 22396362

Estrogens in the time of blood-thinners.

Yosh Taguchi1.   

Abstract

Year:  2012        PMID： 22396362      PMCID： PMC3289690          DOI： 10.5489/cuaj.11140

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  13 in total

1.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

Authors:  Charles Huggins; Clarence V Hodges
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

2.  A phase 1-2 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma.

Authors:  L Klotz; I McNeill; N Fleshner
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

Review 3.  The evolving role of aromatase inhibitors in breast cancer.

Authors:  Kefah Mokbel
Journal:  Int J Clin Oncol       Date:  2002-10       Impact factor: 3.402

Review 4.  The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review.

Authors:  C E Blackard
Journal:  Cancer Chemother Rep       Date:  1975 Jan-Feb

5.  Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer.

Authors:  Douglas Scherr; W Reid Pitts; E Darracott Vaughn
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

6.  Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.

Authors:  D P Byar; D K Corle
Journal:  NCI Monogr       Date:  1988

Review 7.  Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

Authors:  M Aapro; P A Abrahamsson; J J Body; R E Coleman; R Colomer; L Costa; L Crinò; L Dirix; M Gnant; J Gralow; P Hadji; G N Hortobagyi; W Jonat; A Lipton; A Monnier; A H G Paterson; R Rizzoli; F Saad; B Thürlimann
Journal:  Ann Oncol       Date:  2007-09-28       Impact factor: 32.976

Review 8.  Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?

Authors:  Celestia S Higano
Journal:  Nat Clin Pract Urol       Date:  2008-01

9.  Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer.

Authors:  Mark Pomerantz; Judith Manola; Mary-Ellen Taplin; Glenn Bubley; Margaret Inman; Jennifer Lowell; Clair Beard; Philip W Kantoff; William K Oh
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

Review 10.  Estrogens as regulators of bone health in men.

Authors:  Liesbeth Vandenput; Claes Ohlsson
Journal:  Nat Rev Endocrinol       Date:  2009-06-16       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.